4.5 Article

In silico study of cancer stage-specific DNA methylation pattern in White breast cancer patients based on TCGA dataset

Journal

COMPUTATIONAL BIOLOGY AND CHEMISTRY
Volume 92, Issue -, Pages -

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.compbiolchem.2021.107498

Keywords

Methylation; Breast cancer; TCGA; Epigenetics; Biomarker

Funding

  1. Research and Community Engagements Institute (LPPM) of Indonesia International Institute for Life Sciences [001/LoA/LPPM-IBSII/I/2020]

Ask authors/readers for more resources

This study analyzed the methylation pattern of White breast cancer patients across different cancer stages using the TCGA dataset, identifying three potential stage-specific detection biomarkers. These findings suggest ABCC9, SHISA3, and POU4F1 as promising biomarkers for early detection and monitoring of breast cancer in White individuals. Further research is needed to investigate their roles in other racial groups.
Background: Breast cancer is one of the most common types of cancer among women. As current breast cancer treatments are still ineffective, we assess the methylation pattern of White breast cancer patients across cancer stage based on The Cancer Genome Atlas (TCGA) dataset. Significant hypermethylation and hypomethylation can regulate the gene expression, thus becoming potential biomarkers in breast cancer tumorigenesis.& nbsp; Methods: DNA methylation data was downloaded using TCGA Assembler 2 based on race-specific metadata of TCGA - Breast Invasive Carcinoma (TCGA-BRCA) project from Genomic Data Commons (GDC) Data Portal. After the data was divided into each cancer stage, duplicated data of each patient was removed using OMICSBind, while differentially-expressed probes were identified using edgeR. The resulting probes were validated based on correlation and regression analysis with the gene expression, ANOVA between cancer stages, ROC curve per stage, as well as databases.& nbsp; Results: Based on the White dataset, we found 66 significant hypermethylated genes with logFC > 1.8 between Stage I-III. From this number, three epigenetic-regulated, stage-specific genes are proposed to be the detection biomarkers of breast cancer due to significant aberrant gene expression and/or low mutation ratio among breast cancer patients: ABCC9 (Stage III), SHISA3 (Stage II), and POU4F1 (Stage I-II).& nbsp; Conclusions: Our study shows that ABCC9, SHISA3, and POU4F1 are potential stage-specific detection biomarkers of breast cancer for White individuals, whereas their roles in other races need to be studied further.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available